Fuse Science Announces the Launch of Its First Product EnerJel™!
Its Time to Understand What It Means To Be Powered By Fuse™!
AVENTURA, Fla., Dec. 15, 2011 /PRNewswire/ -- Double Eagle Holdings, Ltd. (OTCQB: DROP), the parent company of Fuse Science, Inc. (www.fusescience.com), announced today the formal launch of its first product EnerJel™ which is set for release online from www.poweredbyfuse.com on December 30th, 2011.
"Today we're pleased to announce another milestone for the company," said Aitan Zacharin, Fuse Science Chief Marketing Officer. "We are very deliberate and thorough with the steps we take as a company, and in a very short time we've readied the first of our launches to market! The EnerJel™ product utilizes our proprietary technology in a site specific transdermal application to address muscle soreness & fatigue. It's now time for the world to understand what it means to be Powered By Fuse™ just like Arian Foster and David 'Big Papi' Ortiz!"
http://www.youtube.com/watch?v=ABfjZhJJU9g
The EnerJel™ launch begins officially December 30, 2011. For those that signed up for a free sample, the first 10,000 will be contacted and you can expect them in early January. Soon to follow in 2012 will be the launch of our drop technology and the expansion into retail distribution.
About Double Eagle Holdings
Double Eagle Holdings (OTCQB: DROP) is the parent company of Fuse Science, Inc., an innovative consumer products holding company based in Aventura, Florida. The corporate name, Double Eagle Holdings is in the process of being changed to Fuse Science Inc. Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly – all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science, Inc.
Share this article